Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication. 1984

B F Van Duzee, and J A Schaefer, and J D Ball, and H M Chilton, and R J Cowan, and C Kuni, and R Trow, and N E Watson

To compare the efficacy of Tc-99m HMDP and Tc-99m MDP to define skeletal lesions, 28 adult patients were examined in a double-blind, randomized, crossover study. Each patient was imaged with both agents over a period of 7-14 days. Both quantitative and qualitative evaluations were performed on the resulting images. Both agents detected the same number of skeletal lesions, and the number of lesions detected was the same whether the imaging was performed 2 or 4 hr after injection. Relative uptake of the tracer in the lesion relative to normal bone was also the same for both agents. Lesions were easier to see at 4 hr after injection than at 2 hr, presumably because soft-tissue levels were lower. Retention of tracer in bone compared with soft tissue was greater, and image quality was judged to be better, with Tc-99m HMDP than with Tc-99m MDP.

UI MeSH Term Description Entries
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004164 Diphosphonates Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. Bisphosphonate,Bisphosphonates
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013667 Technetium The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, and atomic number 43. All technetium isotopes are radioactive. Technetium 99m (m Technetium 99m,99m, Technetium
D013669 Technetium Tc 99m Medronate A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumors, it is useful for the detection of neoplasms. Tc-99m MDP,Technetium Methylene Diphosphonate,99mTc-MDP,99mTc-Methylene Diphosphonate,Tc-99 Medronate,Tc-99m Methylene Diphosphonate,Technetium Tc 99m Methylenediphosphonate,99mTc Methylene Diphosphonate,Diphosphonate, 99mTc-Methylene,Diphosphonate, Tc-99m Methylene,Diphosphonate, Technetium Methylene,Medronate, Tc-99,Methylene Diphosphonate, Tc-99m,Methylene Diphosphonate, Technetium,Tc 99 Medronate,Tc 99m Methylene Diphosphonate

Related Publications

B F Van Duzee, and J A Schaefer, and J D Ball, and H M Chilton, and R J Cowan, and C Kuni, and R Trow, and N E Watson
April 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
B F Van Duzee, and J A Schaefer, and J D Ball, and H M Chilton, and R J Cowan, and C Kuni, and R Trow, and N E Watson
March 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
B F Van Duzee, and J A Schaefer, and J D Ball, and H M Chilton, and R J Cowan, and C Kuni, and R Trow, and N E Watson
February 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
B F Van Duzee, and J A Schaefer, and J D Ball, and H M Chilton, and R J Cowan, and C Kuni, and R Trow, and N E Watson
November 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
B F Van Duzee, and J A Schaefer, and J D Ball, and H M Chilton, and R J Cowan, and C Kuni, and R Trow, and N E Watson
October 2021, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
B F Van Duzee, and J A Schaefer, and J D Ball, and H M Chilton, and R J Cowan, and C Kuni, and R Trow, and N E Watson
August 1981, Clinical nuclear medicine,
B F Van Duzee, and J A Schaefer, and J D Ball, and H M Chilton, and R J Cowan, and C Kuni, and R Trow, and N E Watson
May 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
B F Van Duzee, and J A Schaefer, and J D Ball, and H M Chilton, and R J Cowan, and C Kuni, and R Trow, and N E Watson
June 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
B F Van Duzee, and J A Schaefer, and J D Ball, and H M Chilton, and R J Cowan, and C Kuni, and R Trow, and N E Watson
August 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
B F Van Duzee, and J A Schaefer, and J D Ball, and H M Chilton, and R J Cowan, and C Kuni, and R Trow, and N E Watson
June 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!